Effects of Dietary Folate on Ulcerative Colitis-Associated Colorectal Carcinogenesis in the Interleukin 2- and β 2-Microglobulin-deficient Mice

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 11 II, 2003, Pages 1262-1267

  Carrier, Julie ^a   Medline, Alan ^a   Sohn, Kyoung Jin ^a   Choi, Monica ^a   Martin, Rochelle ^c   Hwang, Stephen W ^a,c   Kim, Young In ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; FOLIC ACID; INTERLEUKIN 2;

ANIMAL; ANIMAL DISEASE; ANIMAL MODEL; ARTICLE; CANCER GRADING; CANCER PREVENTION; CELL TRANSFORMATION; CHRONIC DISEASE; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL TUMOR; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE MODEL; DYSPLASIA; FOLIC ACID DEFICIENCY; GENETICS; HUMAN; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ANIMALS; BETA 2-MICROGLOBULIN; CELL TRANSFORMATION, NEOPLASTIC; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; DIET; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; INTERLEUKIN-2; MICE; MICE, INBRED C57BL;

EID: 0242506237     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Eaden, J. A., and Mayberry, J. F. Colorectal cancer complicating ulcerative colitis: a review. Am. J. Gastroenterol., 95: 2710-2719, 2000.
2. Eaden, J. A., Abrams, K. R., and Mayberry, J. F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut, 48: 526-535, 2001.
3. Itzkowitz, S. H. Inflammatory bowel disease and cancer. Gastroenterol. Clin. N. Am., 26: 129-139, 1997.
4. Lashner, B. A., Heidenreich, P. A., Su, G. L., Kane, S. V., and Hanauer, S. B. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology, 97: 255-259, 1989.
5. Lashner, B. A. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J. Cancer Res. Clin. Oncol., 119: 549-554, 1993.
6. Lashner, B. A., Provencher, K. S., Seidner, D. L., Knesebeck, A., and Brzezinski, A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology, 112: 29-32, 1997.
7. D'Argenio, G., Cosenza, V., Delle Cave, M., Iovino, P., Delle Valle, N., Lombardi, G., and Mazzacca, G. Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology, 110: 1727-1734, 1996.
8. Tung, B. Y., Emond, M. J., Haggitt, R. C., Bronner, M. P., Kimmey, M. B., Kowdley, K. V., and Brentnall, T. A. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann. Intern. Med., 134: 89-95, 2001.
9. Eaden, J., Abrams, K., Ekborn, A., Jackson, E., and Mayberry, J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment. Pharmacol. Ther., 14: 145-153, 2000.
10. Kim, Y. I. Folate and carcinogenesis: evidence, mechanisms and implications. J. Nutr. Biochem., 10: 66-88, 1999.
11. Choi, S. W., and Mason, J. B. Folate and carcinogenesis: an integrated scheme. J. Nutr., 130: 129-132, 2000.
12. Cravo, M. L., Mason, J. B., Dayal, Y., Hutchinson, M., Smith, D., Selhub, J., and Rosenberg, I. H. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res., 52: 5002-5006, 1992.
13. Kim, Y. I., Salomon, R. N., Graeme-Cook, F., Choi, S. W., Smith, D. E., Dallal, G. E., and Mason, J. B. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut, 39: 732-740, 1996.
14. Min mouse. Cancer Res., 60: 5434-5440, 2000.
15. Song, J., Sohn, K. J., Medline, A., Ash, C., Gallinger, S., and Kim, Y. I. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res., 60: 3191-3199, 2000.
16. Wargovich, M. J., Jimenez, A., McKee, K., Steele, V. E., Velasco, M., Woods, J., Price, R., Gray, K., and Kelloff, G. J. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis (Lond.), 21: 1149-1155, 2000.
17. Wargovich, M. J., Chen, C. D., Jimenez, A., Steele, V. E., Velasco, M., Stephens, L. C., Price, R., Gray, K., and Kelloff, G. J. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomark. Prev., 5: 355-360, 1996.
18. Le Leu, R. K., Young, G. P., and McIntosh, G. H. Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis (Lond.), 21: 2261-2265, 2000.
19. Selhub, J., Dhar, G. J., and Rosenberg, I. H. Inhibition of folate enzymes by sulfasalazine. J. Clin. Investig., 61: 221-224, 1978.
20. Elsborg, L., and Larsen, L. Folate deficiency in chronic inflammatory bowel diseases. Scand. J. Gastroenterol., 14: 1019-1024, 1979.
21. Simpson, S. J., Mizoguchi, E., Allen, D., Bhan, A. K., and Terhorst, C. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur. J. Immunol., 25: 2618-2625, 1995.
22. Shah, S. A., Simpson, S. J., Brown, L. F., Comiskey, M., de Jong, Y. P., Allen, D., and Terhorst, C. Development of colonic adenocarcinomas in a mouse model of ulcerative colitis. Inflamm. Bowel Dis., 4: 196-202, 1998.
23. 2-microglobulin-deficient mouse. Cancer Res., 61: 6912-6917, 2001.
24. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., and Horak, I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell, 75: 253-261, 1993.
25. Walzem, R. L., and Clifford, A. J. Folate deficiency in rats fed diets containing free amino acids or intact proteins. J. Nutr., 118: 1089-1096, 1988.
26. Rong, N., Selhub, J., Goldin, B. R., and Rosenberg, I. H. Bacterially synthesized folate in rat large intestine is incorporated into host tissue folyl poly-glutamates. J. Nutr., 121: 1955-1959, 1991.
27. Reeves, P. G., Nielsen, F. H., and Fahey, G. C., Jr. ALN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr., 123: 1939-1951, 1993.
28. Riddell, R. H., Goldman, H., Ransohoff, D. F., Appelman, H. D., Fenoglio, C. M., Haggitt, R. C., Ahren, C., Correa, P., Hamilton, S. R., Morson, B. C., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol., 14: 931-968, 1983.
29. Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K., and Tonegawa, S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell, 75: 274-282, 1993.
30. Tamura, T. Microbiological assay of folate. In: M. F. Picciano, E. L. R. Stoksatd, and J. F. Gregory (eds.), Folic Acid Metabolism in Health and Disease, pp. 121-137. New York: Wiley-Liss, 1990.
31. Kim, Y. I., Christman, J. K., Fleet, J. C., Cravo, M. L., Salomon, R. N., Smith, D., Ordovas, J., Selhub, J., and Mason, J. B. Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am. J. Clin. Nutr., 61: 1083-1090, 1995.
32. Bills, N. D., Hinrichs, S. H., Morgan, R., and Clifford, A. J. Delayed tumor onset in transgenic mice fed a low-folate diet. J. Natl. Cancer Inst. (Bethesda), 84: 332-337, 1992.
33. Farber, S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood, 4: 160-167, 1949.
34. Kamen, B. Folate and antifolate pharmacology. Semin. Oncol., 24: S18-30-S18-39, 1997.
35. Jones, P. A., and Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3: 415-428, 2002.
36. Biasco, G., Zannoni, U., Paganelli, G. M., Santucci, R., P., G., Rivolta, G., Miniero, R., Pironi, L., Calabrese, C., Di Febo, G., and Miglioli, M. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol. Biomark. Prev., 6: 469-471, 1997.
37. Einspahr, J. G., Alberts, D. S., Gapstur, S. M., Bostick, R. M., Emerson, S. S., and Gerner, E. W. Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. Cancer Epidemiol. Biomark. Prev., 6: 37-48, 1997.
38. Cravo, M. L., Albuquerque, C. M., Salazar de Sousa, L., Gloria, L. M., Chaves, P., Dias Pereira, A., Nobre Leitao, C., Quina, M. G., and Costa Mira, F. Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation. Am. J. Gastroenterol., 93: 2060-2064, 1998.
39. Boland, C. R. Molecular genetics of hereditary nonpolyposis colorectal cancer. Ann. N. Y. Acad. Sci., 910: 50-59, discussion 59-61, 2000.
40. Brentnall, T. A., Crispin, D. A., Bronner, M. P., Cherian, S. P., Hueffed, M., Rabinovitch, P. S., Rubin, C. E., Haggitt, R. C., and Boland, C. R. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res., 56: 1237-1240, 1996.
41. Lashner, B. A., Shapiro, B. D., Husain, A., and Goldblum, J. R. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am. J. Gastroenterol., 94: 456-462. 1999.
42. Elson, C. O., Sartor, R. B., Tennyson, G. S., and Riddell, R. H. Experimental models of inflammatory bowel disease. Gastroenterology, 109: 1344-1367, 1995.